187 related articles for article (PubMed ID: 37507557)
21. Predominant
Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
[No Abstract] [Full Text] [Related]
22. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
23.
Schultz KAP; Williams GM; Kamihara J; Stewart DR; Harris AK; Bauer AJ; Turner J; Shah R; Schneider K; Schneider KW; Carr AG; Harney LA; Baldinger S; Frazier AL; Orbach D; Schneider DT; Malkin D; Dehner LP; Messinger YH; Hill DA
Clin Cancer Res; 2018 May; 24(10):2251-2261. PubMed ID: 29343557
[TBL] [Abstract][Full Text] [Related]
24. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
[No Abstract] [Full Text] [Related]
25. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.
Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR
JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712
[TBL] [Abstract][Full Text] [Related]
26. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights.
Yeh JM; Stout NK; Chaudhry A; Christensen KD; Gooch M; McMahon PM; O'Brien G; Rehman N; Blout Zawatsky CL; Green RC; Lu CY; Rehm HL; Williams MS; Diller L; Wu AC
Genet Med; 2021 Jul; 23(7):1366-1371. PubMed ID: 33767345
[TBL] [Abstract][Full Text] [Related]
27. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.
Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA
Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes.
Whitworth J; Smith PS; Martin JE; West H; Luchetti A; Rodger F; Clark G; Carss K; Stephens J; Stirrups K; Penkett C; Mapeta R; Ashford S; Megy K; Shakeel H; Ahmed M; Adlard J; Barwell J; Brewer C; Casey RT; Armstrong R; Cole T; Evans DG; Fostira F; Greenhalgh L; Hanson H; Henderson A; Hoffman J; Izatt L; Kumar A; Kwong A; Lalloo F; Ong KR; Paterson J; Park SM; Chen-Shtoyerman R; Searle C; Side L; Skytte AB; Snape K; Woodward ER; ; Tischkowitz MD; Maher ER
Am J Hum Genet; 2018 Jul; 103(1):3-18. PubMed ID: 29909963
[TBL] [Abstract][Full Text] [Related]
29. Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.
Brozou T; Taeubner J; Velleuer E; Dugas M; Wieczorek D; Borkhardt A; Kuhlen M
Eur J Pediatr; 2018 Jan; 177(1):53-60. PubMed ID: 28929227
[TBL] [Abstract][Full Text] [Related]
30. Hematologic indices in individuals with pathogenic germline DICER1 variants.
Vasta LM; Khan NE; Higgs CP; Harney LA; Carr AG; Harris AK; Schultz KAP; McMaster ML; Stewart DR
Blood Adv; 2021 Jan; 5(1):216-223. PubMed ID: 33570641
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Pathogenic Germline
Altaraihi M; Hansen TVO; Santoni-Rugiu E; Rossing M; Rasmussen ÅK; Gerdes AM; Wadt K
Front Endocrinol (Lausanne); 2021; 12():727970. PubMed ID: 34552563
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract][Full Text] [Related]
33. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
34. DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.
Bardón-Cancho EJ; Haro-Díaz A; Alonso-García-de la Rosa FJ; Huerta-Aragonés J; García-Morín M; González-Martínez F; Garrido-Colino C
Fam Cancer; 2017 Apr; 16(2):291-294. PubMed ID: 27830405
[TBL] [Abstract][Full Text] [Related]
35. Childhood Rhabdomyosarcoma of the Female Genital Tract: Association with Pathogenic DICER1 Variation, Clinicopathological Features, and Outcomes.
Kebudi R; Dural O; Bay SB; Gorgun O; Onder S; Bilgic B; Yilmaz I; Iribas A; Arndt CA; Harris AK; Field A; Schultz KAP; Hill DA
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):449-453. PubMed ID: 33484847
[TBL] [Abstract][Full Text] [Related]
36. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC; Viana DV; Kitajima JPFW; Rocha VM; López RVM; Zheng Y; Freitas É; Monteiro FPM; Valim A; Schlesinger D; Kok F; Olopade OI; Folgueira MAAK
Sci Rep; 2022 Mar; 12(1):4190. PubMed ID: 35264596
[TBL] [Abstract][Full Text] [Related]
37. Expanding the spectrum of dicer1-associated sarcomas.
Warren M; Hiemenz MC; Schmidt R; Shows J; Cotter J; Toll S; Parham DM; Biegel JA; Mascarenhas L; Shah R
Mod Pathol; 2020 Jan; 33(1):164-174. PubMed ID: 31537896
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
[TBL] [Abstract][Full Text] [Related]
39. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.
Mezina A; Philips N; Bogus Z; Erez N; Xiao R; Fan R; Olthoff KM; Reddy KR; Samadder NJ; Nielsen SM; Hatchell KE; Esplin ED; Rustgi AK; Katona BW; Hoteit MA; Nathanson KL; Wangensteen KJ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250406
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.
Ceyhan-Birsoy O; Jayakumaran G; Kemel Y; Misyura M; Aypar U; Jairam S; Yang C; Li Y; Mehta N; Maio A; Arnold A; Salo-Mullen E; Sheehan M; Syed A; Walsh M; Carlo M; Robson M; Offit K; Ladanyi M; Reis-Filho JS; Stadler ZK; Zhang L; Latham A; Zehir A; Mandelker D
Genome Med; 2022 Aug; 14(1):92. PubMed ID: 35971132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
